Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Summit Therapeutics Inc. SMMT

Full chart Compare
Set alert

Price alert · SMMT

All alert types
14.19 USD -1.98 (-12.24%)

At closeNov 5, 2026, 7:49 PM EST

14.43 +0.24 +1.69%

After hours · Nov 5, 7:49 PM ET

14.17 Day range 16.12
12.07 52-week range 29.23
YTD
-18.87%
1 year
-21.47%

Financial health

Altman Z-Score

30.87 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

C2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 1

Valuation

P/E -12.1×
FY 2016: -23.8×FY 2017: -31.2×FY 2018: 9.2×FY 2019: -1.7×FY 2020: -8.5×FY 2021: -3.8×FY 2022: -12.5×FY 2023: -3.3×FY 2024: -71.4×FY 2025: -12.1×
FY 2016 5y median -12.1× FY 2025
P/S 0.0×
FY 2016: 214×FY 2017: 44.4×FY 2018: 1.5×FY 2019: 64.5×FY 2020: 518×FY 2021: 185×FY 2022: 1400×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 26.7×
FY 2016: -116×FY 2017: -141×FY 2018: 1.6×FY 2019: 0.6×FY 2020: 5.6×FY 2021: 4.0×FY 2022: 7.9×FY 2023: 26.3×FY 2024: 41.0×FY 2025: 26.7×
FY 2016 5y median 26.3× FY 2025
P/FCF -54.5×
FY 2016: 33.7×FY 2017: -29.6×FY 2018: -2.5×FY 2019: -2.5×FY 2020: -9.1×FY 2021: -4.6×FY 2022: -23.7×FY 2023: -26.6×FY 2024: -112×FY 2025: -54.5×
FY 2016 5y median -26.6× FY 2025
EV/EBITDA -12.0×
FY 2016: -19.1×FY 2017: -22.9×FY 2018: 4.5×FY 2019: 0.5×FY 2020: -7.7×FY 2021: -3.1×FY 2022: -18.6×FY 2023: -23.7×FY 2024: -75.2×FY 2025: -12.0×
FY 2016 5y median -18.6× FY 2025
EV/Sales 0.0×
FY 2016: 199×FY 2017: 42.4×FY 2018: 0.9×FY 2019: -16.0×FY 2020: 441×FY 2021: 147×FY 2022: 1638×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -1.8%
FY 2016: 3.0%FY 2017: -3.4%FY 2018: -40.4%FY 2019: -40.1%FY 2020: -10.9%FY 2021: -21.8%FY 2022: -4.2%FY 2023: -3.8%FY 2024: -0.9%FY 2025: -1.8%
FY 2016 5y median -3.8% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 100.0%FY 2017: 100.0%FY 2018: 98.8%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: -1046.0%FY 2017: -182.3%FY 2018: 9.4%FY 2019: -3697.6%FY 2020: -11392.7%FY 2021: -4764.3%FY 2022: -10225.4%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: -899.5%FY 2017: -142.3%FY 2018: 19.0%FY 2019: -3920.2%FY 2020: -6127.6%FY 2021: -4897.8%FY 2022: -11174.8%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -220.8%
FY 2016: 489.5%FY 2017: 451.8%FY 2018: 19.5%FY 2019: -39.2%FY 2020: -66.0%FY 2021: -106.1%FY 2022: -63.1%FY 2023: -784.6%FY 2024: -56.9%FY 2025: -220.8%
FY 2016 5y median -106.1% FY 2025
ROIC -216.3%
FY 2016: -58.8%FY 2017: -48.5%FY 2018: 8.6%FY 2019: -34.9%FY 2020: -99.5%FY 2021: -96.8%FY 2022: -11.3%FY 2023: -326.0%FY 2024: -56.8%FY 2025: -216.3%
FY 2016 5y median -96.8% FY 2025
ROA -193.6%
FY 2016: -45.5%FY 2017: -25.8%FY 2018: 13.7%FY 2019: -31.8%FY 2020: -51.2%FY 2021: -78.0%FY 2022: -12.0%FY 2023: -300.3%FY 2024: -50.8%FY 2025: -193.6%
FY 2016 5y median -78.0% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 85.5%FY 2017: 496.3%FY 2018: 302.9%FY 2019: -98.9%FY 2020: 2.8%FY 2021: 112.7%FY 2022: -56.4%FY 2023: -100.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -506.3%
FY 2016: -22.2%FY 2017: -3.9%FY 2018: 120.9%FY 2019: -519.8%FY 2020: -216.7%FY 2021: 11.0%FY 2022: 6.4%FY 2023: -701.9%FY 2024: 62.3%FY 2025: -506.3%
FY 2016 FY 2025
EPS (diluted) -476.0%
FY 2016: -2.9%FY 2017: 11.4%FY 2018: 135.5%FY 2019: -763.6%FY 2020: 23.3%FY 2021: -26.8%FY 2022: 52.1%FY 2023: -129.4%FY 2024: 67.9%FY 2025: -476.0%
FY 2016 FY 2025
Free Cash Flow -111.3%
FY 2016: 161.3%FY 2017: -241.1%FY 2018: -65.9%FY 2019: 55.1%FY 2020: -125.2%FY 2021: -51.6%FY 2022: 36.3%FY 2023: -76.8%FY 2024: -86.8%FY 2025: -111.3%
FY 2016 FY 2025

Financial Health

Current Ratio 9.9×
FY 2016: 3.1×FY 2017: 1.6×FY 2018: 3.6×FY 2019: 6.3×FY 2020: 4.4×FY 2021: 3.8×FY 2022: 16.9×FY 2023: 9.3×FY 2024: 10.2×FY 2025: 9.9×
FY 2016 5y median 9.9× FY 2025
Quick Ratio 9.9×
FY 2016: 3.1×FY 2017: 1.6×FY 2018: 3.6×FY 2019: 6.3×FY 2020: 4.4×FY 2021: 3.8×FY 2022: 16.9×FY 2023: 9.3×FY 2024: 10.2×FY 2025: 9.9×
FY 2016 5y median 9.9× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 4.1×FY 2023: 1.4×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.1×
FY 2016: 1.4×FY 2017: 1.1×FY 2018: -3.0×FY 2019: 2.3×FY 2020: 1.3×FY 2021: 0.8×FY 2022: -2.7×FY 2023: -0.4×FY 2024: 0.5×FY 2025: 0.1×
FY 2016 5y median 0.1× FY 2025
Interest Coverage 0.0×
FY 2016: -23.1×FY 2017: 0.0×FY 2018: 8.7×FY 2019: -696×FY 2020: -281×FY 2021: -306×FY 2022: -13.5×FY 2023: -29.1×FY 2024: -20.8×FY 2025: 0.0×
FY 2016 5y median -20.8× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31